Does AXITINIB Cause Hepatic cytolysis? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Hepatic cytolysis have been filed in association with AXITINIB (INLYTA). This represents 0.3% of all adverse event reports for AXITINIB.
48
Reports of Hepatic cytolysis with AXITINIB
0.3%
of all AXITINIB reports
4
Deaths
27
Hospitalizations
How Dangerous Is Hepatic cytolysis From AXITINIB?
Of the 48 reports, 4 (8.3%) resulted in death, 27 (56.3%) required hospitalization, and 3 (6.3%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AXITINIB. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does AXITINIB Cause?
Death (2,222)
Diarrhoea (2,187)
Fatigue (1,816)
Neoplasm progression (1,315)
Hypertension (1,146)
Off label use (1,075)
Nausea (955)
Decreased appetite (920)
Dysphonia (871)
Disease progression (768)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which AXITINIB Alternatives Have Lower Hepatic cytolysis Risk?
AXITINIB vs AZACITIDINE
AXITINIB vs AZATHIOPRINE
AXITINIB vs AZD-1222
AXITINIB vs AZELAIC ACID
AXITINIB vs AZELASTINE